SEC Form D private-offering filing
Virax Biolabs Group Ltd
A new SEC Form D private-offering notice from Lanarkshire, a $5,000,000 filer-stated offering target in Biotech. The source filing is one click away.
Nasdaq listed biotechnology company developing T cell based immune profiling diagnostics for viral diseases and post viral conditions such as Long COVID
Filed 2025-12-18Filed to raise $5,000,000First money in 2025-12-03Raised so far $5,000,000HQ (as filed) LanarkshireSector Biotech ✓Stage (inferred) EarlyCall status Needs classification
Source linked the Form D on EDGAR↗Website verified viraxbiolabs.com↗Named in the filing 5 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.